EUVIMEDEUVIMED entdecken
Crossref

Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease

Gregory A Panza, Olivia Blazek, Joseph Tortora, Stephanie Saucier, Antonio B Fernandez

Journal of Clinical Lipidology · 2023-11 · 17 (6) · 748-755

DOI: 10.1016/j.jacl.2023.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2023-11. Verfasst von Gregory A Panza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hartford Healthcare, Hartford, CT (Drs Panza, Tortora, Saucier, Fernandez). Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Lipoprotein(a) [Lp(a)] is a genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease. Despite recommendations from professional societies in the cardiovascular field, the awareness of elevated Lp(a) as a risk factor and screening for Lp(a) are suspected to be low. METHODS: We conducted a retrospective, observational case control study of patient charts from January 1, 2017 to June 19, 2022. The primary aims were 1) to describe the proportion of patients at the healthcare network's primary care and cardiology clinics that met Lp(a) screening criteria and were tested; and 2) to describe the proportion of patients throughout the entire healthcare network that had Lp(a) measured. RESULTS: Of the 2,412,020 patient charts in the health network, only 5,942 (0.25 %) had Lp(a) measured. Of the 84,581 patients in primary care or cardiology clinics who met screening criteria, only 1,311 (1.55 %) had Lp(a) measured. Patients with Lp(a) measured were more likely to be younger, non-Hispanic/Latinx, had a lipid panel measured, a cardiac computed tomography (CT) imaging study, and higher low-density lipoprotein-cholesterol. Patients with ASCVD, heart failure, ischemic heart disease, aortic stenosis, peripheral vascular disease, or a stroke did not feature highly among patients who received Lp(a) testing. Having an abnormal or risk-enhancing Lp(a) level was associated with being female and/or being Black/African American. CONCLUSIONS: Despite increased awareness of Lp(a) and its contribution to cardiovascular disease there exists a paucity of testing. Increased Lp(a) testing can identify patients who have an increased cardiovascular risk underestimated by other metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtherosclerosisHumansFemaleMaleRetrospective StudiesPrevalenceCase-Control StudiesRisk FactorsLipoprotein(a)

Stichwörter der Autor:innen

ASCVDAortic valve diseaseAtherosclerosisCardiovascular diseaseCholesterolLipoprotein(a)Lp(a)

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Hartford Healthcare, Hartford, CT (Drs Panza, Tortora, Saucier, Fernandez).
  • University of Chicago School of Medicine, Chicago, IL (Dr Blazek).
  • Hartford Healthcare, Hartford, CT (Drs Panza, Tortora, Saucier, Fernandez). Electronic address: Antonio.Fernandez@hhchealth.org.

Zitieren

APA

Panza, G. A., Blazek, O., Tortora, J., Saucier, S., & Fernandez, A. B. (2023). Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease. Journal of Clinical Lipidology, 17(6), 748-755. https://doi.org/10.1016/j.jacl.2023.09.016

Vancouver

Panza GA, Blazek O, Tortora J, Saucier S, Fernandez AB. Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease. Journal of Clinical Lipidology. 2023;17(6):748-755. doi:10.1016/j.jacl.2023.09.016

BibTeX
@article{Panza2023,
  author = {Panza, Gregory A and Blazek, Olivia and Tortora, Joseph and Saucier, Stephanie and Fernandez, Antonio B},
  title = {Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease},
  journal = {Journal of Clinical Lipidology},
  year = {2023},
  volume = {17},
  number = {6},
  pages = {748--755},
  doi = {10.1016/j.jacl.2023.09.016}
}
Kostenlos starten →